Dual role of Response gene to complement-32 in multiple sclerosis-Reference-Cited by-同舟云学术

Dual role of Response gene to complement-32 in multiple sclerosis

Published:2013-02 Issue:1 Volume:94 Page:17-28
ISSN:0014-4800
Container-title:Experimental and Molecular Pathology
language:en
Short-container-title:Experimental and Molecular Pathology

Author:

Tegla Cosmin A.,Cudrici Cornelia D.,Azimzadeh Philippe,Singh Anil K.,Trippe Richard,Khan Ali,Chen Hegang,Andrian-Albescu Maria,Royal Walter,Bever Christopher,Rus Violeta,Rus Horea

Funder

MS Society

Veterans Administration Merit Award

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference39 articles.

1. Death ligands and autoimmune demyelination;Aktas;The Neuroscientist,2006

2. Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes;Badea;Journal of Biological Chemistry,1998

3. RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase;Badea;Journal of Biological Chemistry,2002

4. C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIP;Cudrici;Journal of Immunology,2006

5. Dendritic cells are abundant in non-lesional gray matter in multiple sclerosis;Cudrici;Experimental and Molecular Pathology,2007

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RGC-32 mediates proinflammatory and profibrotic pathways in immune-mediated kidney disease;Clinical Immunology;2024-08

2. Role of RGC-32 in multiple sclerosis and neuroinflammation – few answers and many questions;Frontiers in Immunology;2022-09-12

3. A Scoping Review on Body Fluid Biomarkers for Prognosis and Disease Activity in Patients with Multiple Sclerosis;Journal of Personalized Medicine;2022-08-31

4. Therapeutic Effect of IL-21 Blockage by Gene Therapy in Experimental Autoimmune Encephalomyelitis;Neurotherapeutics;2022-07-28

5. RGC-32 Acts as a Hub to Regulate the Transcriptomic Changes Associated With Astrocyte Development and Reactive Astrocytosis;Frontiers in Immunology;2021-07-29